
    
      This study compares a new oral Nicotine Replacement Therapy (NRT) product with NiQuitin™
      lozenge 4 mg and Nicorette®gum 4 mg, after 12 hours of nicotine abstinence, with respect to
      nicotine pharmacokinetics, during 12 hours after start of administration. Single doses of
      each treatment are given once in the morning during five separate treatment visits scheduled
      in a crossover setting with randomized treatment sequences. The study will include 45 healthy
      smokers between 18-50 years, who have been smoking at least 15 cigarettes daily during at
      least one year preceding inclusion. Subjects and study personnel will be aware of which
      treatment is administered at a given visit.
    
  